Axl is essential for VEGF-A-dependent activation of PI3K/Akt

被引:170
|
作者
Ruan, Guo-Xiang [1 ]
Kazlauskas, Andrius [1 ]
机构
[1] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst,Dept Ophthalmol, Boston, MA 02114 USA
来源
EMBO JOURNAL | 2012年 / 31卷 / 07期
关键词
angiogenesis; Axl; PI3K; VEGF-A; VEGFR-2; ENDOTHELIAL GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; SRC-FAMILY KINASES; PDGF RECEPTOR; ANGIOGENESIS; CELLS; RANIBIZUMAB; ASSOCIATION; REGULATOR; LETHALITY;
D O I
10.1038/emboj.2012.21
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Herein, we report that vascular endothelial growth factor A (VEGF-A) engages the PI3K/Akt pathway by a previously unknown mechanism that involves three tyrosine kinases. Upon VEGF-A-dependent activation of VEGF receptor-2 (VEGFR-2), and subsequent TSAd-mediated activation of Src family kinases (SFKs), SFKs engage the receptor tyrosine kinase Axl via its juxtamembrane domain to trigger ligand-independent autophosphorylation at a pair of YXXM motifs that promotes association with PI3K and activation of Akt. Other VEGF-A-mediated signalling pathways are independent of Axl. Interfering with Axl expression or function impairs VEGF-A- but not bFGF-dependent migration of endothelial cells. Similarly, Axl null mice respond poorly to VEGF-A-induced vascular permeability or angiogenesis, whereas other agonists induce a normal response. These results elucidate the mechanism by which VEGF-A activates PI3K/Akt, and identify previously unappreciated potential therapeutic targets of VEGF-A-driven processes. The EMBO Journal (2012) 31, 1692-1703. doi: 10.1038/emboj.2012.21; Published online 10 February 2012
引用
收藏
页码:1692 / 1703
页数:12
相关论文
共 50 条
  • [31] Activation of the oncogene ERG by the Ras/ERK and PI3K/AKT pathways
    Strittmatter, Brady G.
    Hollenhorst, Peter
    CANCER RESEARCH, 2019, 79 (13)
  • [32] Immunologic and metabolic consequences of PI3K/AKT/mTOR activation in melanoma
    Nanda, Vashisht G. Y.
    Peng, Weiyi
    Hwu, Patrick
    Davies, Michael A.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [33] PI3K/AKT/mTOR activation in esophageal carcinomas in Greek population
    Saetta, A.
    Tasioudi, K. E.
    Sakellariou, S.
    Levidou, G.
    Michalopoulos, N. V.
    Kontogianni, P.
    Theodorou, D.
    Korkolopoulou, P.
    Patsouris, E.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 316 - 317
  • [34] Activation of the PI3K/AKT pathway and its regulation by thioredoxin in neuroblastoma
    Sartelet, H.
    Rougemont, A.
    Fabre, M.
    Bosq, J.
    Oligny, L.
    Vassal, G.
    VIRCHOWS ARCHIV, 2009, 455 : 156 - 156
  • [35] PI3K/Akt signaling in osteosarcoma
    Zhang, Jian
    Yu, Xiao-Hua
    Yan, Yi-Guo
    Wang, Cheng
    Wang, Wen-Jun
    CLINICA CHIMICA ACTA, 2015, 444 : 182 - 192
  • [36] The development of inhibitors of PI3K and Akt
    Dennis, PA
    ANNALS OF ONCOLOGY, 2006, 17 : 24 - 24
  • [37] Activation of the PI3K/Akt Pathway is Essential for the Survival of Brucella melitensis 16M In Vitro and In Vivo
    Zhang, Junbo
    Yin, Shuanghong
    Guo, Fei
    Li, Zhiqing
    Chen, Chuangfu
    Zhang, Hui
    PAKISTAN VETERINARY JOURNAL, 2015, 35 (01) : 7 - 12
  • [38] Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway
    Bortul, R
    Tazzari, PL
    Billi, AM
    Tabellini, G
    Mantovani, I
    Cappellini, A
    Grafone, T
    Martinelli, G
    Conte, R
    Martelli, AM
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (05) : 677 - 686
  • [39] IRX2-mediated upregulation of MMP-9 and VEGF in a PI3K/AKT-dependent manner
    Liu, Tielong
    Zhou, Weiwei
    Cai, Bing
    Chu, Jianjun
    Shi, Guodong
    Teng, Honglin
    Xu, Jian
    Xiao, Jianru
    Wang, Yan
    MOLECULAR MEDICINE REPORTS, 2015, 12 (03) : 4346 - 4351
  • [40] Simultaneous Inhibition of PI3Kδ and PI3Kα Induces ABC-DLBCL Regression by Blocking BCR-Dependent and -Independent Activation of NF-κB and AKT
    Paul, Juliane
    Soujon, Maurice
    Wengner, Antje M.
    Zitzmann-Kolbe, Sabine
    Sturz, Andrea
    Haike, Katja
    Magdalene, Koh Hui Keng
    Tan, Sze Huey
    Lange, Martin
    Tan, Soo Yong
    Mumberg, Dominik
    Lim, Soon Thye
    Ziegelbauer, Karl
    Liu, Ningshu
    CANCER CELL, 2017, 31 (01) : 64 - 78